During the last decade, carbonic anhydrase became an attractive and promising scientific target for anticancer therapy since two cancer-associated isozymes CA IX and XII [29,34,35,36,37,38,39,40] were found to be overexpressed in many tumors [41,42]. This evidence concerns the gene CA9 and cancer.